Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
756.00    -4.50 (-0.59%)
Bid:
754.50
Ask:
755.50
Spread: 1.00 (0.133%)
Market Cap: £2.54b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Infrastructure debt facility

14 Sep 2020 14:04

RNS Number : 9331Y
Drax Group PLC
14 September 2020
 

14 September 2020

Drax Group plc

("Drax", the "Group" or the "Company"; Symbol: DRX)

 

Infrastructure debt facility - extended maturity profile, reduced cost of debt

 

Drax is pleased to announce that it has agreed a new infrastructure term loan facilities agreement (the "Agreement") that provides committed facilities of approximately £160 million with a range of maturities between 2024 and 2030(1), further extending Drax's debt maturity profile.

 

The facilities have an average margin of 2.07%(2). Taken together with Drax's existing borrowing, including a carbon-linked ESG(3) facility which was recently extended to 2025, this Agreement further reduces the Group's all-in cost of debt below 4%.

 

The Agreement also includes an option for Drax to obtain up to a further £75 million of facilities, if agreed between Drax and its lenders. If utilised, these additional facilities could have a maturity of up to 2030.

 

The facilities under this Agreement also have a delayed draw(4) and proceeds are expected to be used in the ordinary course of business.

 

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Selina Williams

+44 (0) 7912 230 393

 

Website: www.drax.com

 

END

 

Note

(1) €25 million in 2024, €70 million in 2026, £45 million in 2027 and €31.5 million in 2030.

Euro facilities have been converted to £GBP for the purposes of this announcement only at a rate of €1.10/GBP£1. Drax intends that foreign exchange hedging of any Euro funds into £GBP will take place in advance of drawing funds.

(2) Linked to LIBOR and EURIBOR. The weighted average margin of the facilities including the annual amortised cost in relation to duration fees.

(3) The Environmental, Social and Governance (ESG) facility includes a mechanism that adjusts the rate of interest paid based on Drax's carbon emissions against an annual benchmark, reflecting Drax's continued commitment to reducing its carbon emissions as a part of its overall purpose of enabling a zero-carbon, lower cost energy future and an ambition to become carbon negative by 2030

(4) Six months, with the exception of the €31.5 million facility due in 2030 which can be drawn up to 13 November 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKKQBKNBKDDCD
Date   Source Headline
18th Aug 20239:35 amRNSTransaction in Own Shares
10th Aug 202312:30 pmRNSUK Biomass Strategy - Highly supportive of biomass
4th Aug 20237:29 amRNSTransaction in Own Shares
1st Aug 20231:52 pmRNSTotal Voting Rights
31st Jul 20233:30 pmRNSDirector/PDMR Shareholding
28th Jul 20234:30 pmRNSHolding(s) in Company
27th Jul 20237:04 amRNSHalf Year Results Webcast Arrangements
27th Jul 20237:00 amRNSHalf-year Report
24th Jul 202311:46 amRNSHolding(s) in Company
20th Jul 20234:10 pmRNSHolding(s) in Company
20th Jul 20239:30 amRNSNotice of Results
19th Jul 20237:30 amRNSTransaction in Own Shares
18th Jul 20231:01 pmRNSHolding(s) in Company
18th Jul 20237:30 amRNSTransaction in Own Shares
17th Jul 20237:30 amRNSTransaction in Own Shares
13th Jul 20237:30 amRNSTransaction in Own Shares
12th Jul 20237:30 amRNSTransaction in Own Shares
11th Jul 20232:40 pmRNSHolding(s) in Company
11th Jul 20237:30 amRNSTransaction in Own Shares
10th Jul 20237:30 amRNSTransaction in Own Shares
7th Jul 202310:33 amRNSHolding(s) in Company
7th Jul 20237:30 amRNSTransaction in Own Shares
6th Jul 20234:50 pmRNSHolding(s) in Company
6th Jul 20237:30 amRNSTransaction in Own Shares
3rd Jul 20235:06 pmRNSHolding(s) in Company
3rd Jul 20234:59 pmRNSTotal Voting Rights
30th Jun 20235:06 pmRNSHolding(s) in Company
30th Jun 20237:30 amRNSTransaction in Own Shares
29th Jun 202311:17 amRNSHolding(s) in Company
29th Jun 20237:30 amRNSTransaction in Own Shares
28th Jun 20237:30 amRNSTransaction in Own Shares
27th Jun 20234:38 pmRNSHolding(s) in Company
27th Jun 20237:30 amRNSTransaction in Own Shares
26th Jun 20237:30 amRNSTransaction in Own Shares
23rd Jun 20237:30 amRNSTransaction in Own Shares
22nd Jun 20237:30 amRNSTransaction in Own Shares
21st Jun 20237:30 amRNSTransaction in Own Shares
20th Jun 20237:30 amRNSTransaction in Own Shares
19th Jun 20237:30 amRNSTransaction in Own Shares
16th Jun 20237:30 amRNSTransaction in Own Shares
15th Jun 20233:47 pmRNSHolding(s) in Company
15th Jun 20239:31 amRNSHolding(s) in Company
15th Jun 20237:30 amRNSTransaction in Own Shares
14th Jun 20237:30 amRNSTransaction in Own Shares
13th Jun 20237:30 amRNSTransaction in Own Shares
12th Jun 20237:30 amRNSTransaction in Own Shares
9th Jun 20234:55 pmRNSHolding(s) in Company
9th Jun 20237:30 amRNSTransaction in Own Shares
8th Jun 20237:30 amRNSTransaction in Own Shares
7th Jun 20234:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.